AimaLabs is a med-tech company developing an AI-powered, hardware-independent SaaS platform for automated peripheral blood smear analysis. Founded by Dr. Vasiliki Vlacha, a Pediatric Hematologist-Oncologist with +35 years of clinical experience, alongside Dr. Christos Maniatis (PhD, Machine Learning) and Daniel Tikhomirov (aPhD University of Cambridge), the company addresses a critical diagnostic crisis: of the 5 billion Complete Blood Counts (CBCs) performed worldwide annually, 1 in 4 leukemia patients face avoidable diagnostic delays, and basic CBC alone misses 1 in 4 outpatient leukemia cases — gaps that close to zero when blood smear review is added.
Unlike existing systems requiring over €100,000 in capital expenditure, AimaLabs automates the missing smear review step in under two minutes, using standard laboratory equipment already in place — a scalable, affordable solution for hospitals and laboratories of every size, worldwide.